Budesonide–formoterol reliever therapy in intermittent versus mild persistent asthma

Overview of attention for article published in European Respiratory Journal, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 8,020 followers.

RT @some4mv: Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma https://t.co/9kkRFtYUMj #SoMe4MV from Pap…

RT @some4mv: Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma https://t.co/9kkRFtYUMj #SoMe4MV from Papi, A., Braithwaite, I., Ebmeier, S., Hancox, R. J., Harrison, T., Holliday, M., Houghton, C., Morandi, L., Oldfield,…

Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma https://t.co/9kkRFtYUMj #SoMe4MV from Papi, A., Braithwaite, I., Ebmeier, S., Hancox, R. J., Harrison, T., Holliday, M., Houghton, C., Morandi, L., Oldfield, K., Pavord, …

Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma https://t.co/TGVyO28OP7 @NottmBRC @UoNresearch

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.